Opendata, web and dolomites

OcuTher SIGNED

Educational Network in Ocular Drug Delivery and Therapeutics

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "OcuTher" data sheet

The following table provides information about the project.

Coordinator
ITA-SUOMEN YLIOPISTO 

Organization address
address: YLIOPISTONRANTA 1 E
city: KUOPIO
postcode: 70211
website: www.uef.fi

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Finland [FI]
 Project website http://www.ocuther.eu
 Total cost 3˙933˙728 €
 EC max contribution 3˙933˙728 € (100%)
 Programme 1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
 Code Call H2020-MSCA-ITN-2016
 Funding Scheme MSCA-ITN-ETN
 Starting year 2016
 Duration (year-month-day) from 2016-11-01   to  2020-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ITA-SUOMEN YLIOPISTO FI (KUOPIO) coordinator 807˙436.00
2    UNIVERSITEIT UTRECHT NL (UTRECHT) participant 635˙356.00
3    THE QUEEN'S UNIVERSITY OF BELFAST UK (BELFAST) participant 546˙575.00
4    UNIVERSITA DEGLI STUDI DI PADOVA IT (PADOVA) participant 516˙122.00
5    EBERHARD KARLS UNIVERSITAET TUEBINGEN DE (TUEBINGEN) participant 373˙824.00
6    CERTARA UK LIMITED UK (LONDON) participant 273˙287.00
7    OZ BIOSCIENCES SAS FR (MARSEILLE) participant 262˙875.00
8    UNIVERSITE DE STRASBOURG FR (STRASBOURG) participant 262˙875.00
9    TECHNISCHE UNIVERSITEIT EINDHOVEN NL (EINDHOVEN) participant 255˙374.00
10    20MED THERAPEUTICS BV NL (ENSCHEDE) partner 0.00
11    BAYER AKTIENGESELLSCHAFT DE (Leverkusen) partner 0.00
12    Bio-Ker s.r.l IT (Gessate) partner 0.00
13    DELSITECH OY FI (TURKU) partner 0.00
14    INNOCORE TECHNOLOGIES BV NL (Groningen) partner 0.00
15    Retina International CH (Zürich) partner 0.00
16    SLASKI UNIWERSYTET MEDYCZNY W KATOWICACH PL (KATOWICE) partner 0.00
17    UNIVERSIDAD COMPLUTENSE DE MADRID ES (MADRID) partner 0.00
18    Vasgen ltd UK (London) partner 0.00

Map

 Project objective

Ocular drug development has transformed from niche area to a major field in drug development in which many companies, including European big pharma has entered recently. Ocular drug development is a unique field in terms of drug targets and end-points of activity, local drug administration routes, tissue barriers and pharmacokinetics, drug delivery and formulation challenges and local toxicity issues. These issues are slowing down the development of drugs for the unmet needs in ophthalmology. The main objective of the proposal is to educate experts of preclinical ocular R&D to facilitate the success of European pharmaceutical industry and research community. This objective will be reached by joining forces of the leading European academic and industrial researchers in ophthalmology, materials science and nanomedicine, drug delivery and targeting, and systems pharmacology. We shall educate 15 Early Stage Researchers in a network where they will receive tailored, multi-disciplinary and inter-sectoral education in preclinical ocular drug development. The thesis projects are directed to the drug treatment of retinal diseases, the major challenge in the field. The proposal combines new drug candidates from the experts of ophthalmology, innovative drug delivery technologies from pharmaceutical scientists and companies, and modern in vitro, in silico and in vivo methods from various partners. The thesis projects include secondments in academic and industrial partner laboratories and course programme that encompasses the relevant fields in ocular drug development. Therefore, this proposal presents unique combination of innovation and education in the field with obvious need for such education. The ESRs and other outcomes of this project will greatly benefit the future competitiveness of European science and industry in this field of expanding importance.

 Deliverables

List of deliverables.
Call for applications Other 2019-07-09 09:56:59
First online version of network public website Websites, patent fillings, videos etc. 2019-07-09 09:56:59

Take a look to the deliverables list in detail:  detailed list of OcuTher deliverables.

 Publications

year authors and title journal last update
List of publications.
2020 MD Al-Amin, Federica Bellato, Francesca Mastrotto, Mariangela Garofalo, Alessio Malfanti, Stefano Salmaso, Paolo Caliceti
Dexamethasone Loaded Liposomes by Thin-Film Hydration and Microfluidic Procedures: Formulation Challenges
published pages: 1611, ISSN: 1422-0067, DOI: 10.3390/ijms21051611
International Journal of Molecular Sciences 21/5 2020-04-04
2020 Jian Liu, Miao Tang, Kevin Harkin, Xuan Du, Chang Luo, Mei Chen, Heping Xu
Single‐cell RNA sequencing study of retinal immune regulators identified CD47 and CD59a expression in photoreceptors—Implications in subretinal immune regulation
published pages: , ISSN: 0360-4012, DOI: 10.1002/jnr.24618
Journal of Neuroscience Research 2020-04-01
2019 Daye Sun, Miao Tang, Li Zhang, Brian G Falzon, Dilli Babu Padmanaban, Davide Mariotti, Paul Maguire, Heping Xu, Mei Chen, Dan Sun
Microplasma assisted synthesis of gold nanoparticle/graphene oxide nanocomposites and their potential application in SERS sensing
published pages: 455603, ISSN: 0957-4484, DOI: 10.1088/1361-6528/ab2a23
Nanotechnology 30/45 2020-04-01

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "OCUTHER" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "OCUTHER" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.1.)

BIGMATH (2018)

Big Data Challenges for Mathematics

Read More  

DISTINCT (2019)

Dementia: Intersectorial Strategy for Training and Innovation Network for Current Technology (DISTINCT)

Read More  

NanoCarb (2018)

Glyco-Nanoparticles for Applications in Advance Nanomedicine

Read More